Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

NIAID initiates phase I study of a trispecific broadly neutralizing antibody against HIV

May 6, 2019

FDA approves Dovato for treatment-naive HIV-1

April 9, 2019

Human TRIM5-alpha active against HIV

March 28, 2019

Pharmacokinetic data on VRC-01 LS in HIV-exposed newborns reported

March 11, 2019

GlaxoSmithKline's GSK-2838232 shows activity in phase IIa study in patients with HIV

March 11, 2019

Interim phase I data reported for GS-6207

March 11, 2019

Gilead presents first data for anti-HIV antibody GS-9722

March 11, 2019

CROI 2019: With additional long-term remission, number of possible HIV cures doubles to 2

March 5, 2019

ViiV Healthcare enters collaboration with Radboud University Medical Center

March 1, 2019

New phase I trial evaluates MK-8527 in ART-naive patients with HIV-1

Feb. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...